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NK cells are innate immune lymphocytes with 
potent effector functions against infected and 
tumor cells. NK cells integrate signals received 
through target cell ligand-mediated engage-
ment of activation receptors with those from 
inhibitory receptor engagement by MHC class I 
ligands expressed on targets. Absence of MHC 
class I on target cells often leads to NK cell ac-
tivation. This phenomenon, termed “missing-
self,” allows NK cells to attack and eliminate cells 
with aberrantly low or absent expression of 
MHC class I (Kärre et al., 1986), as with trans-
formed or virally infected cells. Hence, NK cells 
use inhibitory receptors to assess the surface of 
self-tissues for MHC class I expression, provid-
ing a line of defense against pathogens and ab-
normal cell growth.
MHC class I molecules are also crucial to 
acquisition of effector function by NK cells in 
vivo as NK cells from MHC class I–deficient 
hosts are defective in natural killing (Bix et al., 
1991; Höglund et al., 1991) and hyporespon-
sive to triggering through their activation re-
ceptors (Fernandez et al., 2005; Kim et al., 2005). 
Recent data obtained in MHC-sufficient hosts 
support the hypothesis that cognate interaction 
between inhibitory receptors and self-MHC 
is necessary for acquisition of effector function. 
For example, Ly49C+ NK cells, which bind a 
self-MHC I ligand (H2Kb) in the H2b haplo-
type of C57BL/6 mice, display more robust 
production of cytokines upon stimulation than 
NK cells expressing only Ly49A, which has 
no H2b ligand (Kim et al., 2005). This is most 
evident in a C57BL/6 transgenic (Tg) mouse 
expressing a single-chain trimer H2Kb (SCT-Kb) 
molecule, consisting of the H2Kb heavy chain 
covalently linked to 2-microglobulin (2m) 
and the SIINFEKL peptide from ovalbumin. 
In mice where SCT-Kb is the only MHC class I 
molecule expressed, i.e., SCT-Kb Tg mouse 
on the Kb/Db/2m/ (triple KO; TKO) 
background, and Ly49C is the sole NK cell re-
ceptor capable of binding the SCT-Kb mole-
cule, only Ly49C+ NK cells display the licensed 
phenotype (Kim et al., 2005). Thus, engage-
ment of self–MHC-specific receptor “licenses” 
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In MHC class I–deficient hosts, natural killer (NK) cells are hyporesponsive to cross-linking 
of activation receptors. Functional competence requires engagement of a self–major  
histocompatability complex (MHC) class I–specific inhibitory receptor, a process referred  
to as “licensing.” We previously suggested that licensing is developmentally determined in 
the bone marrow. In this study, we find that unlicensed mature MHC class I–deficient 
splenic NK cells show gain-of-function and acquire a licensed phenotype after adoptive 
transfer into wild-type (WT) hosts. Transferred NK cells produce WT levels of interferon- 
after engagement of multiple activation receptors, and degranulate at levels equivalent  
to WT NK cells upon coincubation with target cells. Only NK cells expressing an  
inhibitory Ly49 receptor specific for a cognate host MHC class I molecule show this gain-
of-function. Therefore, these findings, which may be relevant to clinical bone marrow 
transplantation, suggest that neither exposure to MHC class I ligands during NK develop-
ment in the BM nor endogenous MHC class I expression by NK cells themselves is absolutely 
required for licensing.
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after the publication date (see http://www.rupress.org/terms). After six months it 
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identical to host-derived 2m/ NK cells (Fig. 1 A). This 
was equivalent to the hyporesponsive production of IFN- 
by NK cells from unmanipulated 2m/ control animals 
(unpublished data). Therefore, adoptive transfer of hypore-
sponsive splenic NK cells appeared to result in the acquisition 
of activation receptor responses that correlated with host NK 
cell responsiveness.
It may seem surprising that donor-derived MHC-deficient 
cells could be detected because WT host NK cells can elimi-
nate MHC class I–deficient BM and splenocyte grafts (Bix et al., 
1991; Höglund et al., 1991). However, transfer of a suffi-
ciently large number of cells can result in BM graft accep-
tance (Cudkowicz and Bennett, 1971; Koh et al., 2005), and 
NK cells to be functionally competent to be triggered through 
their activation receptors.
Although there has been debate on the meaning of the 
term “licensing,” most groups now agree that the engage-
ment of inhibitory receptors by self–MHC class I results in 
education of NK cells to become functionally competent 
(Anfossi et al., 2006; Raulet and Vance, 2006). Moreover, 
such education effects have also been observed with human 
NK cells via self-HLA recognition by killer immunoglobulin-
like receptors (KIRs), which are related by convergent evo-
lution to murine Ly49 receptors (Kelley et al., 2005; Anfossi 
et al., 2006; Yu et al., 2007; Kim et al., 2008). Thus, self–
MHC class I engagement by NK cell inhibitory receptors 
appears to be a fundamental element in acquisition of NK cell 
effector function.
Conventional murine NK cells are thought to develop 
primarily, if not completely, in the BM where they progress 
through a series of stages en route to full maturation (Di Santo, 
2006; Kim et al., 2002). After this process, they leave the BM 
and populate the peripheral tissues. Egress from the BM is 
generally accepted as a marker of mature conventional NK 
cells, as cells isolated from peripheral lymphoid tissues demon-
strate effector function upon stimulation. We previously hy-
pothesized licensing to be a developmental process because 
Ly49 receptors are first expressed at an immature stage during 
NK cell maturation in the BM (Kim et al., 2002). Thereafter, 
developing NK cells undergo constitutive proliferation that 
appears to be influenced by MHC class I and the relevant 
Ly49 receptor (Kim et al., 2005). However, it is not known if 
licensing can occur outside the context of development within 
the BM, or whether the unlicensed phenotype is fixed.
Herein, we performed adoptive transfer of peripheral, 
hyporesponsive NK cells from MHC class I–deficient donors 
to MHC class I–sufficient hosts, resulting in the generation of 
functional donor NK cells. Expression of a host MHC class I 
ligand specific for a donor cell inhibitory NK cell receptor 
was necessary for the observed gain of function, which is 
highly suggestive of licensing as a mechanism. We conclude 
that the unlicensed phenotype is not fixed in apparently ma-
ture peripheral NK cells, and that licensing may not be exclu-
sively a developmental process in the BM.
RESULTS AND DISCUSSION
MHC class I–deficient NK cells gain function after transfer 
to MHC I-sufficient hosts
To examine potential for gain of function by hyporespon-
sive, peripheral MHC class I–deficient NK cells, we harvested 
and labeled 2m/ splenocytes with CFSE and injected 
them into MHC class I–sufficient WT (C57BL/6) or control 
2m/ hosts. At day 7, host spleens were harvested and bulk 
splenocytes were activated in vitro by anti-NK1.1 cross-linking, 
and then analyzed for intracellular IFN-. Surprisingly, we 
found that donor-derived MHC class I–deficient 2m/ 
NK cells in WT hosts produced IFN- at a level equivalent 
to that of host WT NK cells (Fig. 1 A). In contrast, 2m/ 
donor cells in 2m/ hosts produced IFN- at a frequency 
Figure 1. Ly49C+ MHC class I–deficient NK cells gain function 
after transfer to WT hosts. Splenocytes were purified from 2m/ 
donors, labeled with CSFE, and adoptively transferred i.v. into WT 
(C57BL/6) or 2m/ hosts. Recipient splenocytes were harvested at day 7,  
stimulated with anti-NK1.1, and analyzed for intracellular IFN-.  
(A) Representative dot plots depict IFN- production versus Ly49C expres-
sion on gated donor (CSFE+) or host (CSFE) NKp46+ CD3 NK cells. Num-
bers indicate percentage of cells in each quadrant. (B) Summary of IFN- 
production by Ly49C+ (left) and Ly49C (right) donor (2m/) and host 
NK cells recovered 7 d after adoptive transfer into WT or 2m/ hosts 
after anti-NK1.1 stimulation. Results from anti-NK1.1 stimulation of un-
manipulated WT NK cells are shown. Data are pooled from three indepen-
dent experiments, with three to five mice/group. Means are shown as 
horizontal lines with error bars representing SEM.
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splenocytes into MHC class I–expressing hosts, there is a se-
lective gain of function in NK cells expressing an inhibitory 
receptor capable of interacting with host MHC class I.
To extend these findings to other inhibitory Ly49 recep-
tors and MHC ligands, we transferred 2m/ NK cells into 
KODO (Kb/Db/) D8 hosts, which lack H2b MHC class Ia 
heavy chains and display Tg expression of H2Dd, a ligand 
for Ly49A (Karlhofer et al., 1992). After transfer, we ob-
served a gain in IFN- production among Ly49A+ MHC 
class I–deficient NK cells (Fig. 2 A), consistent with enhanced 
responsiveness of Ly49A+ NK cells in H2Dd-expressing mice 
(Kim et al., 2005). Thus, we confirmed that there was a se-
lective gain of function for transferred NK cells expressing 
another inhibitory receptor able to bind to a different host 
MHC class I molecule.
We consistently observed that Ly49C– NK cells in WT 
hosts, and Ly49A– NK cells in KODO D8 hosts, trended to-
ward greater IFN- production than their counterparts from 
MHC class I–deficient hosts (Fig. 1 and Fig. 2 A). Although 
these findings were not statistically significant, we hypothe-
sized that expression of other self-MHC–specific receptors 
may contribute to this effect. To investigate this hypothesis, 
we transferred 2m/ NK cells into SCT-Kb Tg TKO hosts, 
which express only a single MHC class I molecule (SCT-Kb) 
we suspect the same process may be occurring here. Regard-
less, host NK cells did not demonstrate increased responsive-
ness as compared with NK cells from unmanipulated controls 
(Fig. 1 B) and did not display markers associated with activa-
tion (not depicted). Thus, we found no evidence for host NK 
cell activation that may have accounted for the phenotypic 
change in the donor NK cells.
It was possible that the gain of function observed for 
transferred MHC class I–deficient cells could be caused by 
their coincubation with WT splenocytes during in vitro 
stimulation. To test this possibility, we mixed freshly isolated 
2m/ and WT splenocytes at various ratios and stimulated 
them under the conditions used for the analyses of adoptively 
transferred cells. Regardless of the presence of WT cells in 
co-culture, 2m/ NK cells retained their hyporesponsive 
phenotype after receptor cross-linking (Fig. S1). These results 
indicate that the gain of function of the 2m/ NK cells 
after adoptive transfer to WT hosts is imparted during resi-
dence in the MHC class I–sufficient environment, not during 
co-culture and stimulation.
As we and others have recently shown that previously ac-
tivated NK cells exhibit a memory-like property of enhanced 
cytokine production upon restimulation (Cooper et al., 2009; 
Sun et al., 2009), we sought to determine if our current re-
sults could reflect prior donor NK cell activation. Although 
kinetic studies revealed that donor NK cells gained function 
at WT levels by day 4 after transfer and that their phenotype 
was stable thereafter (Fig. S2), donor 2m/ NK cells did 
not spontaneously produce IFN- or display markers of acti-
vation, such as CD69, at any time (Fig. S3 and not depicted). 
Prior studies also showed that previously activated NK cells 
displaying the memory-like phenotype preferentially prolif-
erate upon transfer (Cooper et al., 2009; Sun et al., 2009). 
In contrast, donor 2m/ NK cells did not proliferate after 
residence in WT hosts, as indicated by a lack of CFSE dilution 
(Fig. S3 A). Collectively, these data indicate that 2m/ NK 
cells were not activated after adoptive transfer to WT hosts, 
suggesting that acquisition of functional competence is un-
related to a memory-like phenotype.
Gain of function is restricted to cells expressing inhibitory 
Ly49 receptor specific for host MHC class I
We next examined if the NK cells acquiring function had 
properties of licensed NK cells. Such cells would be expected 
to express a receptor specific for an MHC class I allele in the 
WT host. In particular, Ly49C is an inhibitory NK cell recep-
tor with an H2b ligand, H2Kb (Kim et al., 2005). We hypoth-
esized that if transfer of hyporesponsive 2m/ NK cells into 
an H2b environment results in licensing, we would observe a 
higher frequency of IFN-+ donor NK cells among the 
Ly49C+ population than the Ly49C population. Indeed, 
transferred 2m/ Ly49C+ NK cells made IFN- at a signifi-
cantly higher frequency than Ly49C NK cells (P = 0.02; 
Fig. 1 B). Additionally, similar results were observed after stimu-
lation through another NK cell activation receptor, Ly49H 
(Fig. S4). Therefore, after adoptive transfer of MHC-deficient 
Figure 2. Inhibitory receptor and cognate MHC I ligand are re-
quired for gain-of-function. (A) Summary of IFN- production by 
Ly49A+ (left) and Ly49A (right) donor (2m/) and host NK cells recov-
ered 7 d after adoptive transfer from 2m/ or KODO D8 (KD8) hosts 
after anti-NK1.1 stimulation. Results from anti-NK1.1 stimulation of un-
manipulated KODO D8 NK cells are shown. Data were pooled from four 
independent experiments, with three to eight mice/group. (B) Summary of 
IFN- production by Ly49C+ (left) or Ly49C (right) donor (2m/) or 
host NK cells recovered 7 d after adoptive transfer from 2m/ or  
SCT-Kb Tg TKO (SCT) hosts, after ex vivo stimulation via anti-NK1.1.  
Results from anti-NK1.1 stimulation of unmanipulated SCT NK cells are 
shown. Data were pooled from three independent experiments with three 
to seven mice/group. Means are shown as horizontal lines with error bars 
representing SEM.
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at a slightly higher level on WT NK cells when compared 
with 2m/ NK cells, and their expression slightly increased 
on 2m/ NK cells after their transfer to WT hosts. There-
fore, there were minimal changes overall in the expression of 
most surface molecules after adoptive transfer of 2m/ cells 
to WT hosts.
In contrast to the minimal changes in expression of most 
surface markers, we found a distinct and reproducible de-
crease of Ly49C mean fluorescence intensity (MFI) on MHC 
class I–deficient cells after adoptive transfer to WT C57BL/6 
hosts (Fig. 5 A). This effect was observed for multiple systems 
in which the inhibitory Ly49 receptors had a known MHC 
class I ligand in the host (Fig. 5, A–C). In particular, decreased 
that binds only one NK cell receptor, Ly49C (Kim et al., 2005). 
After adoptive transfer, donor Ly49C+ NK cells gained the 
ability to produce IFN- at levels equivalent to that of host 
Ly49C+ cells (Fig. 2 B). However, there was no increase in 
IFN- production by either donor or host Ly49C NK cells. 
Therefore, the interaction between an inhibitory Ly49 re-
ceptor and its cognate self–MHC class I ligand is necessary 
for the gain of function observed in hyporesponsive MHC 
class I–deficient NK cells after their adoptive transfer to 
MHC class I–sufficient hosts, consistent with licensing.
Gain of function extends to NK cell degranulation
MHC class I–deficient NK cells are defective in their cyto-
kine production capacity and in their ability to kill targets as 
compared with WT NK cells (Bix et al., 1991; Höglund et al., 
1991). As killing is dependent on degranulation, we exposed 
transferred NK cells to sensitive targets and assessed the level 
of surface CD107a (LAMP-1), a marker for NK cell degran-
ulation (Fig. 3). Additionally, NK cells were assessed after 
transfer into Jinx mice, which have a mutation in Unc13d 
(Crozat et al., 2007). The Jinx mice provide the baseline level 
of CD107a staining because their NK cells are unable to de-
granulate. After transfer to MHC class I–expressing hosts, 
2m/ NK cells gained the ability to degranulate at a level 
equivalent to that of host and control WT NK cells in re-
sponse to YAC targets (Fig. 3). In contrast, 2m/ NK cells 
adoptively transferred to 2m/ hosts show defective de-
granulation, comparable to Jinx NK cells. Furthermore, as 
with cytokine production, we found no increase in the abil-
ity of freshly isolated 2m/ NK cells to degranulate in re-
sponse to target cells when coincubated with WT NK cells in 
the degranulation assay (Fig. S5). Collectively, these data in-
dicate that the gain of function (degranulation) observed in 
MHC class I–deficient cells is acquired after their residence 
in the WT host environment.
Specific decrease in inhibitory receptor MFI on MHC  
class I–deficient cells after transfer
Previous studies indicate that splenic NK cells from 2m- 
deficient animals are mature and indistinguishable from peri-
pheral NK cells in WT mice (Huntington et al., 2007; Joncker 
and Raulet, 2008; Kim et al., 2002; Sun and Lanier, 2008). 
Nevertheless, one potential mechanism for the gain of func-
tion by transferred 2m/ NK cells could be differentiation 
of the NK cells after transfer. To further evaluate this possi-
bility, the surface phenotype of 2m/ donor cells was as-
sessed after recovery from WT hosts at 7 d after adoptive 
transfer, a time when donor cells possess the capacity for nor-
mal cytokine production and degranulation (Fig. S2 and 
Fig. 3). These experiments indicate that, regardless of the 
genotype of the host or donor, all NK cells appeared pheno-
typically indistinguishable in most aspects. For example, mark-
ers such as NK1.1, CD94, NKG2A, CD69, DX5, and 2B4 
showed no difference in expression between 2m/ and 
WT NK cells, before or after adoptive transfer (Fig. 4). Other 
markers, such as NKp46, NKG2D, and CD11b were expressed 
Figure 3. MHC class I–deficient NK cells gain WT degranulation 
capacity after adoptive transfer into MHC class I–sufficient hosts. 
Splenocytes were purified from 2m/ donors and adoptively transferred 
into WT, 2m/ or Jinx hosts. On day 7, recipient splenocytes were har-
vested, coincubated with YAC target cells, and assayed for surface CD107a 
expression. (A) Representative dot plots showing CD107a expression on 
NK cells gated on Ly5.1+ (donor) or Ly5.1 (host) CD3NK1.1+ cells. Figures  
show the percentage of cells positive for CD107a staining. (B) Summary of 
CD107a surface expression by host and donor NK cells after incubation 
with target cells. Data are representative from three independent experi-
ments, with two to three mice/group for adoptive transfer donor and host 
cells, and one to two mice/group for controls. Means are shown as hori-
zontal lines with error bars representing SEM.
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have become fully mature. Thus, although it is possible that 
licensing may occur during NK cell development in vivo, 
these results demonstrate that licensing is not exclusively a 
developmental process in the BM.
In the current experiments, adoptive transfer of NK cells 
from an MHC-deficient background was performed without 
host irradiation and subset depletion, thereby minimizing the 
impact of experimental manipulation on host and donor NK 
cells. Because WT host NK cells can reject MHC class I– 
deficient grafts (Bix et al., 1991; Höglund et al., 1991), it is 
possible that host NK cells could have been activated and 
influenced the function of transferred donor cells. However, 
we found no evidence of any host NK cell activation. Most 
importantly, restriction of the gain of function to only those 
NK cells bearing an inhibitory receptor specific for self-
MHC, as was observed, would not be expected if NK cells 
had been activated by a broad stimulus, such as cytokine 
stimulation. Thus, it appears that acquisition of activation re-
ceptor responsiveness by the MHC-deficient NK cells is a 
cell-intrinsic property, consistent with a licensed phenotype.
NK cell receptor–ligand interactions can occur in either 
trans (on different cells) or in cis (on the same NK cell). Im-
portantly, the licensed phenotype of the donor MHC- 
deficient NK cells in the MHC-sufficient environment indicates 
that NK cell-intrinsic expression of MHC class I is not strictly 
a requirement for licensing. This seems to be consistent with 
trans effects and contradictory to studies suggesting that cis 
interactions are necessary for education (Chalifour et al., 2009). 
However, numerous works indicate that NK cells can acquire 
Ly49C MFI was specifically observed in cells transferred to the 
SCT-Kb Tg TKO mice (Fig. 5 B), whereas MFI of Ly49A, a 
receptor for which no MHC class I ligand is present in this host, 
remained unchanged (Fig. 5 D). However, Ly49A MFI de-
creased on cells transferred into KODO D8 mice that express 
the ligand for Ly49A (Fig. 5 C). Thus, decreased Ly49 MFI ap-
pears to reflect a specific interaction of an inhibitory receptor on 
a donor NK cell with a host MHC class I molecule.
Herein, we found that introduction of MHC class I– 
deficient NK cells into an MHC class I–sufficient host results 
in their acquisition of function, as demonstrated by their in-
creased capacity for cytokine production and degranulation 
upon activation receptor cross-linking. The requirement that 
MHC class I–deficient NK cells express an inhibitory recep-
tor specific for host MHC class I to become functional can be 
interpreted as evidence that these cells become licensed in the 
MHC class I–sufficient host. Importantly, these experiments 
suggest that licensing of NK cells can occur after their egress 
from the BM, after the time at which they are believed to 
Figure 4. Minimal changes in surface phenotype of MHC class I–
deficient NK cells after adoptive transfer to WT hosts. At day 7 after 
adoptive transfer of 2m/ splenocytes to WT hosts, unstimulated NK 
cells were assessed for NK receptor or marker expression by flow cytom-
etry. Control staining of NK cells from unmanipulated WT or 2m/ mice 
are shown. Data are representative from two experiments per condition, 
with each point representing one individual spleen. Mean MFI is shown as 
horizontal bars. *, P < 0.02; **, P < 0.002; ***, P < 0.0005.
Figure 5. Specific reduction in inhibitory Ly49 receptor expression 
on MHC I-deficient donor NK cells after adoptive transfer into 
MHC class I–expressing hosts. Splenocytes from 2m/ donors were 
adoptively transferred into indicated hosts. At day 7, unstimulated recipi-
ent splenocytes were assessed for Ly49C (A and B) or Ly49A (C and D) 
surface expression. Control staining from unmanipulated mice are shown, 
as indicated. Data are from two to three experiments per condition, with 
each point representing one individual spleen. Mean MFI is shown as 
horizontal bars. **, P < 0.004; ***, P < 0.0001.
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Antibodies and flow cytometry. The following antibodies and reagents 
were purchased from BD: anti-CD3 (145-2C11), anti-Ly5.1 (A20), anti-
Ly5.2 (104), anti-NK1.1 (PK136), anti-Ly49A (JR9 and A1), anti-CD69 
(H1.2F3), streptavidin APC (SA-APC), SA-PerCP-Cy5.5, and SA-PE-Cy7. 
The following antibodies were purchased from eBioscience: anti-NKp46 
(29A1.4), anti-IFN- (XMG1.2), anti-KbOVA (eBio25-D1.16), anti-CD94 
(18d3), anti-NKG2D (CX5), anti-CD11b (M1/70), anti-CD127 (A7R34), 
anti-CD49 (DX5), and anti-CD107a (eBio1D4B). Anti-Ly49C (4LO33) 
and anti-Ly49H were purified in our laboratory from hybridoma superna-
tants. (The 4LO33 hybridoma was generously provided by Suzanne Lemieux, 
Institut National de la Recherche Scientifique-Institut Armand-Frappier, 
Laval, Quebec, Canada.) All surface staining was performed on ice in stain-
ing buffer (3% FCS, 0.1% NaN3 in PBS) containing anti-FcR antibodies 
(2.4G2). Samples were collected on a FACSCanto (BD) using FACSDiva 
software (BD), and data were analyzed using FlowJo (Tree Star, Inc.).
Adoptive transfer and co-culture. For adoptive transfer experiments, donor 
splenocytes were purified from 2m/ mice, red-blood cell lysed, and la-
beled with 1 µM CFSE (CellTrace; Invitrogen). Cells were washed twice in 
PBS and resuspended at 2.5 × 108 splenocytes/ml PBS. 200 µl of the cell sus-
pension was injected into the lateral tail vein of age- and sex-matched recipient 
mice. For co-culture experiments, freshly isolated RBC-lysed splenocytes 
from C57BL/6 Ly5.1 and 2m/ donors were plated in 6-well plates at ratios 
indicated in the figures, with 1.0 × 107 cells/ml of R10 media (RPMI, 10% 
FCS, l-glutamine, and pen-strep)/well. For the kinetic analysis, a single donor 
population was prepared and injected into multiple recipients, which were 
analyzed on varying days after transfer using the same set of reagents.
In vitro stimulation and intracellular cytokine staining. Splenocytes 
were harvested from adoptive transfer recipients 7 d after transfer and stimu-
lated with anti-NK1.1 (or anti-Ly49H) mAb as previously described (Kim 
et al., 2005). In brief, 107 splenocytes were plated into 6-well plates, that 
were either precoated with antibody (5 µg/ml; 1.5 h at 37°C), contained 
media alone, or contained media with 0.5 µg phorbol myristate acetate 
(Sigma-Aldrich) and 4 µg ionomycin (Calbiochem). Cells were incubated 
for 1 h at 37°C in 5%CO2. Brefeldin A (GolgiPlug; BD) was added, and cells 
were incubated for an additional 7 h. Cells were then fixed and permeabi-
lized (Cytofix/Cytoperm; BD), followed by antibody staining for intracellu-
lar IFN-, as previously described (Kim et al., 2005).
Degranulation assay. Splenocytes were harvested from adoptive-transfer 
recipients at day 7 after transfer, and NK cells were purified using magnetic 
separation columns (MACS NK isolation kit; Miltenyi Biotech,). Separation 
purity was determined via flow cytometry (gating on CD3 NK1.1+ cells), 
and NK cells were plated with target cells at a ratio of 1:1 (E:T) in 96-well 
V-bottom plates. Anti-CD107a antibody and monensin (eBioscience) were 
added to each well before incubation. Plates were incubated for 2 h at 37°C, 
after which surface staining for flow cytometry was performed as described 
in Antibodies and flow cytometry.
Statistical analysis. Data are presented as mean ± SD. Statistics were gen-
erated using unpaired Student’s t test within GraphPad Prism software 
(GraphPad), and P values <0.05 were considered significant.
Online supplemental material. Fig. S1 shows MHC class I–deficient and 
WT NK cells retain distinct cytokine production phenotypes during spleno-
cyte co-culture. Fig. S2 shows MHC class I–deficient NK cells gain function 
72 h after transfer into WT hosts. Fig. S3 shows that MHC class I–deficient 
NK cells do not proliferate and do not constitutively produce IFN- after 
adoptive transfer into WT hosts. Fig. S4 shows selective gain-of-function by 
MHC class I–deficient NK cells expressing an inhibitory receptor specific for 
host-MHC class I after activation through an alternate stimulus. Fig. S5 shows 
that MHC class I–deficient and WT NK cells retain distinct degranulation 
phenotypes during splenocyte co-culture. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20100986/DC1.
plasma membrane components from other cells, in a process 
termed trogocytosis (Carlin et al., 2001; Sjöström et al., 2001; 
Zimmer et al., 2001). This may result in the accumulation 
of enough cognate MHC ligand on the surface of 2m/ 
donor NK cells sufficient to induce the licensing state by cis 
interactions. Previous studies have suggested that the decreased 
MFI in this context can be caused, at least in part, by cis 
interactions (Zimmer et al., 2001; Andersson et al., 2007). 
Consistent with this possibility, we found a correlation be-
tween decreased MFI for a Ly49 receptor specific for host 
MHC and the licensed phenotype. Importantly, a similar de-
crease in inhibitory receptor MFI was reported after adoptive 
transfer of WT splenocytes to hosts with Tg MHC I-expression 
(Kåse et al., 1998), supporting our observations and suggest-
ing that the phenomenon of decreased inhibitory receptor 
MFI after exposure to MHC I is not an irregularity of MHC I-
deficient cells. Regardless of the mechanism, our data indi-
cate that NK cells may not need to produce their own MHC 
ligand to be licensed.
In summary, our data indicate that NK cell function in 
respect to host MHC environment is more plastic than origi-
nally anticipated, as in vivo exposure of a peripheral cell to 
the presence of an inhibitory ligand can alter the functional 
capacity of the NK cell. As such, these results may have im-
portant clinical implications. In particular, patients undergo-
ing BM transplantation experience greater donor-mediated 
anti-leukemic effect when donor NK cells express KIRs spe-
cific for HLA lacking in the patient (for review see Grzywacz 
et al., 2008). Therefore, within the context of the transfer of 
peripheral NK cells, such as NK immunotherapy, donor NK 
cells unlicensed by HLA alleles absent in the donor may be-
come licensed by host HLA alleles, leading to a beneficial 
gain in reactivity of donor NK cells against host tumors lack-
ing HLA expression. Perhaps prospective pairing of donor 
KIR along with donor and host HLA to anticipate gain of 
function by otherwise unlicensed donor NK cells may en-
hance patient outcomes.
MATERIALS AND METHODS
Mice. C57BL/6 mice were purchased from the National Cancer Institute 
(Frederick, MD). C57BL/6 Ly5.1 congenic mice and 2m/ mice were 
purchased from The Jackson Laboratory. 2m/ Ly5.1 mice were gener-
ated by crossing 2m/ mice with Ly5.1 mice (both from The Jackson 
Laboratory). H2Kb/H2Db/H2Dd-expressing mice (KODO D8) were 
generated by crossing H2Kb/H2Db/ mice (Taconic Farms) with mice 
expressing a Dd-transgene (D8), provided by D. Marguiles (National In-
stitute of Allergy and Infectious Diseases, Bethesda, MD). TKO Kb/ 
Db/2m/ mice with Tg expression of Kb-OVA MHC class I as a 
single protein (SCT-Kb Tg TKO mice) were a gift from T. Hansen 
(Washington University, Saint Louis, MO). Jinx mice, harboring a muta-
tion in UNC13D, were provided by B. Beutler (Scripps Research Insti-
tute, La Jolla, CA) and have been previously described (Crozat et al., 
2007). Genotyping was performed by the Speed Congenics core facility, 
supported by the Rheumatic Disease Core Center grant to Washington 
University. Animals were housed in specific pathogen–free facilities at 
Washington University in Saint Louis, and all mice were used between 
6 and 14 wk of age. Experiments were conducted in accordance with the 
animal protocol approved by the Animal Studies Committee at Washing-
ton University in Saint Louis.
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